Loading...
PERRIGO COMPANY — Guaifenesin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Guaifenesin · $850.0K import value · 17 shipments · UNITED STATES · DGFT Verified
PERRIGO COMPANY is the #3 importer of Guaifenesin from India with $850.0K in import value and 17 verified shipments. PERRIGO COMPANY holds a 3.2% market share in Guaifenesin imports based in UNITED STATES. The company sources from 1 verified supplier across 6 formulations shipped to 1 country.
Verified from 17 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GRANULES INDIA LIMITED | $850.0K | 17 | 100.0% |
PERRIGO COMPANY sources Guaifenesin from 1 verified Indian supplier based on 17 customs records. The primary supplier is GRANULES INDIA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | SHREE HARI INTERNATIONAL LLC | UNITED STATES | $665.9K | 24 | $27.7K |
| 10 | GRANULES USA INC | UNITED STATES | $643.6K | 15 | $42.9K |
| 3 | PERRIGO COMPANY ★ | UNITED STATES | $600.0K | 12 | $50.0K |
| 12 | OHM LABORATORIES INC. | UNITED STATES | $514.1K | 22 | $23.4K |
| 7 | PRODOSE INC. | UNITED STATES | $500.0K | 10 | $50.0K |
PERRIGO COMPANY ranks #3 among 278 Guaifenesin importers from India. Average shipment value of $50.0K compared to the market average of $52.3K. The closest competitors by value are SHREE HARI INTERNATIONAL LLC and GRANULES USA INC.
Destination countries from 17 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $850.0K | 17 | 100.0% |
PERRIGO COMPANY imports Guaifenesin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $850.0K.
| Formulation | Value | Shipments |
|---|---|---|
| Guaifenesin Extended Release Tablets 120 | $500.0K | 10 |
| Guaifenesin Extended Release Tablets 1200mg 14s/Perrigo | $150.0K | 3 |
| Guaifenesin Extended Release Tablets 1200mg 14s/Perrigo USA NDC: 62207-840-99 Perrigo Part 4A65KAA | $50.0K | 1 |
| Guaifenesin Extended Release Tablets 1200mg 14s/Perrigo USA NDC: 62207-840-99 Perrigo Part # 4A65KAA | $50.0K | 1 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG 14S/PERRIGO USA (NDC: 62207-840-99PERRIGO PART # 4A65KAA) | $50.0K | 1 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG 14S/PERRIGO USA (128400.000 PACKS) | $50.0K | 1 |
PERRIGO COMPANY imports 6 distinct Guaifenesin formulations from India. The top formulation is Guaifenesin Extended Release Tablets 120 with 10 shipments worth $500.0K.
What PERRIGO COMPANY and other importers must comply with to import Guaifenesin from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $14.5M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. PERRIGO COMPANY imports $850.0K of this total, accounting for 3.2% of India's Guaifenesin exports with 17 shipments from UNITED STATES. This is verified from 17 customs shipment records covering 6 distinct formulations.
PERRIGO COMPANY's average Guaifenesin order value is $50.0K per consignment, based on 17 shipments totaling $850.0K. PERRIGO COMPANY is based in UNITED STATES and ranks #3 among all Guaifenesin importers from India by value. The company sources from 1 verified supplier in India.
PERRIGO COMPANY sources Guaifenesin from 1 verified Indian supplier: GRANULES INDIA LIMITED ($850.0K, 100.0%). This is based on 17 customs records.
PERRIGO COMPANY ranks #3 among 278 Guaifenesin importers from India with a 3.2% market share. The top 3 importers are GRANULES CONSUMER HEALTH ($5.8M), SPIRIT PHARMACEUTICALS LLC ($1.8M), GRANULES USA INC. ($905.1K). PERRIGO COMPANY processed 17 shipments from UNITED STATES.
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for PERRIGO COMPANY's Guaifenesin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PERRIGO COMPANY
Company Profile
Multiple products · $0 total trade · Multiple categories
Verified from customs records
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for PERRIGO COMPANY.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current order-level data, contact TransData Nexus.